GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (FRA:TUO0) » Definitions » Cyclically Adjusted PB Ratio

Terumo (FRA:TUO0) Cyclically Adjusted PB Ratio : (As of Jun. 21, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Terumo Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Terumo Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Terumo's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Cyclically Adjusted PB Ratio Chart

Terumo Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.30 5.26 4.41 3.69 4.97

Terumo Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.69 4.57 3.84 4.36 4.97

Competitive Comparison of Terumo's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Terumo's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Terumo's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Terumo's Cyclically Adjusted PB Ratio falls into.



Terumo Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Terumo's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Terumo's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.489/107.2000*107.2000
=5.489

Current CPI (Mar. 2024) = 107.2000.

Terumo Quarterly Data

Book Value per Share CPI Adj_Book
201406 2.358 98.000 2.579
201409 2.550 98.500 2.775
201412 2.589 97.900 2.835
201503 2.905 97.900 3.181
201506 2.796 98.400 3.046
201509 2.825 98.500 3.075
201512 2.944 98.100 3.217
201603 2.801 97.900 3.067
201606 2.762 98.100 3.018
201609 2.882 98.000 3.153
201612 3.044 98.400 3.316
201703 2.890 98.100 3.158
201706 2.869 98.500 3.122
201709 2.839 98.800 3.080
201712 2.943 99.400 3.174
201803 2.975 99.200 3.215
201806 3.290 99.200 3.555
201809 3.663 99.900 3.931
201812 3.723 99.700 4.003
201903 3.741 99.700 4.022
201906 3.810 99.800 4.093
201909 4.084 100.100 4.374
201912 4.172 100.500 4.450
202003 4.217 100.300 4.507
202006 4.158 99.900 4.462
202009 4.112 99.900 4.412
202012 4.087 99.300 4.412
202103 4.378 99.900 4.698
202106 4.357 99.500 4.694
202109 4.613 100.100 4.940
202112 4.812 100.100 5.153
202203 5.125 101.100 5.434
202206 5.212 101.800 5.488
202209 5.480 103.100 5.698
202212 5.045 104.100 5.195
202303 5.213 104.400 5.353
202306 5.273 105.200 5.373
202309 5.366 106.200 5.417
202312 5.212 106.800 5.232
202403 5.489 107.200 5.489

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Terumo  (FRA:TUO0) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Terumo Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Terumo's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Terumo (FRA:TUO0) Business Description

Comparable Companies
Traded in Other Exchanges
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Terumo (FRA:TUO0) Headlines

No Headlines